References
- Comité de l'antibiogramme de la Societe Frangaise de Mi-crobiologie: recommandations 2007. Downloaded from Internet: http://www.sfm.asso.fr/
- Batard E, Jacqueline C, Boutoille D et al. Combination of quinupristin-dalfopristin and gentamicin against methicillin-resis-tant Staphylococcus aureus : experimental rabbit endocarditis study. Antimicrob Agents Chemother 2002; 46 (7): 2174-2178.
- Duez JM, Cordin X, Siebor E, Péchinot A, Chamard-Neuwirth C, Kazmierczak A. [A three-dimensional model to study a combination of three antibiotics in vitro . Application to the bactericidal activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria according to their beta-lac- tam resistance pattern] (in French). Path Biol 1998; 46 (1): 67–72.
- Eliopoulos GM, Eliopoulos CT. Antibiotic combinations: should they be tested? Clin Microbiol Rev 1988; 1 (2): 139-156. Kang LS, Rybak MJ. Pharmocodynamics of RP 59500 alone and in combination with vancomycin against Staphylo-coccus aureus in an in vitro-infected fibrin clot model. Antimi-crob Agents Chemother 1995; 39 (7): 1505-1511.
- Odds FC - Synergy, antagonism, and what the chequer-board puts between them. J Antimicrob Chemother 2003; 52:1
- Allen GP, Cha R, Rybak MJ. In vitro activities of quin-upristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant Staphylococci and Enterococci in an in vitro pharmacodynamic model. Antimi-crob Agents Chemother 2002; 46 (8): 2606–2612.
- Fuchs PC, Barry AL, Brown SD. Interactions of quin-upristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal. An-timicrob Agents Chemother 2001; 45 (9): 2662–2665.
- Grif K, Dierich MP, Pfaller K, Miglioli PA, Allerberger F. In vitro activity of fosfomycin in combination with various anti-staphylococcal substances. J Antimicrob Chemother 2001; 48: 209–217.
- Kang LS, Rybak MJ. In-vitro bactericidal activity of quin-upristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus. J Antimicrob Chemother 1997; 39: Suppl. A, 33-39.
- Pavie J, Lefort A, Zarrouk V, et al. Efficacies of quin-upristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylo-coccus aureus in relation to cross-resistance to macrolides, lin-cosamides, and streptogramin B-type antibiotics. Antimicrob Agents Chemother 2002; 46 (9): 3061–3064.
- Sambatakou H, Giamarellos-Bourboulis EJ, Grecka P, Chryssouli Z, Giamarellou H. In-vitro activity and killing effect of quinupristin/dalfopristin (RP 59500) on nosocomial Staphylo-coccus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates. J Antimicrob Chemother 1998; 41: 349–355.
- Zarrouk V, Bozdogan B, Leclercq R, et al. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lin-cosamide-streptogramin antibiotics. Antimicrob Agents Chemother 2001; 45 (4): 1244-1248. Erratum, 2001, 45 (6), 1941.
- Duez JM, Kohli E, Péchinot A, Bryskier A, Kazmierczak A — [In vitro activity of the combination tetracycline-erythromycin against bacterial strains responsive of respiratory tract infections] (in French). Lyon Medical 1985; 253 (4): 119–121.
- Berenbaum MC. A method for testing for synergy with any number of agents. J Infect Dis 1978; 137 (2): 122–130.
- Yu VL, Felegie TP, Yee RB, Pasculle AW, Taylor FH. Synergistic interaction in vitro with use of three antibiotics si-multaneously against Pseudomonas maltophilia. J Infect Dis 1980; 142 (4): 602–607.